Movement Disorders
Conference Coverage
Worsening motor function tied to post COVID syndrome in Parkinson’s disease
About half of the study participants with Parkinson’s disease who developed post–COVID-19 syndrome experienced worsening motor symptoms and needed...
Conference Coverage
Novel drug effective for essential tremor, but with significant side effects
Patients receiving the drug saw significant reduction in upper-limb tremors, but adverse events led many to discontinue treatment.
Conference Coverage
Apple devices identify early Parkinson’s disease
Study results show clear differences in a finger-tapping task in the Parkinson’s disease versus control group.
Conference Coverage
Study identifies pandemic-related stressor in Parkinson’s disease
Researchers in the Netherlands identified COVID-19–related stressors for people with Parkinson’s disease and the most vulnerable subgroups.
Conference Coverage
Investigative botulinum toxin formulation shows prolonged effect
A phase 3 trial reported that a new formulation of a botulinum toxin had a longer duration of effect with fewer side effects than existing...
Conference Coverage
Efforts target underrepresented populations in Parkinson’s disease genetic studies
Genetic studies in Parkinson’s disease have been heavily skewed to European populations, but a number of efforts aim to make study populations...
Conference Coverage
Surge in new-onset tics in adults tied to COVID-19 stress
“All patients, including those with organic tic disorders, had a history of anxiety and also reported worsening anxiety in the setting of the...
Conference Coverage
Sublingual film well tolerated for Parkinson ‘off’ episodes
While using the sublingual apomorphine film, the majority of patients did not have dose-limiting nausea or vomiting.
Conference Coverage
Friedreich’s ataxia treatment shows extended benefit
An extension study of the Nrf2 activator omaveloxolone in people with Friedreich’s ataxia showed benefit out to more than 2 years.
Conference Coverage
Survey identifies clinicians’ unease with genetic testing
A survey of Movement Disorders Society members identified a number of gaps in clinicians’ comfort levels with genetic testing for Parkinson’s...
Feature
Toward ‘superhuman cognition’: The future of brain-computer interfaces
Among the big players in this area of research is billionaire entrepreneur Elon Musk, who in 2016 founded Neuralink.